US Broker Ratings

Align Technology, Inc. (ALGN) Stock Analysis: Potential Upside of 14.86% Amidst Industry Challenges

Align Technology, Inc. (NASDAQ: ALGN) stands as a prominent figure in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $14.66 billion, Align..

Quest Diagnostics (DGX) Stock Analysis: Is a 9.42% Upside Within Reach?

Quest Diagnostics Incorporated (NYSE: DGX) stands as a prominent player in the healthcare sector, particularly in diagnostics and research. With a substantial market cap of $18.76 billion, the company has..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: A Deep Dive into Its 43% Potential Upside

Teva Pharmaceutical Industries (NYSE: TEVA) is a prominent name within the healthcare sector, specifically among drug manufacturers specializing in both specialty and generic products. Based in Israel, Teva has a..

West Pharmaceutical Services, Inc. (WST) Stock Analysis: Exploring a 22.74% Upside Potential

West Pharmaceutical Services, Inc. (NYSE: WST), a notable player in the healthcare sector, continues to captivate investor attention with its robust business model and promising growth prospects. As a key..

Intuitive Surgical, Inc. (ISRG) Investor Outlook: Analyzing the 12.39% Potential Upside

Investors with a keen eye on the healthcare sector will find Intuitive Surgical, Inc. (NASDAQ: ISRG) an intriguing prospect. With a market cap of $183.53 billion, this industry leader in..

GSK plc (GSK) Stock Analysis: Discovering Potential Upside in Healthcare Giant

GSK plc (NYSE: GSK) stands as a formidable player in the global healthcare sector, deeply embedded in drug manufacturing with a strong focus on vaccines, specialty medicines, and general medicines...

Johnson & Johnson (JNJ) Stock Analysis: Exploring a 7.83% Potential Upside Amidst Robust Dividend Yield

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, continues to hold a commanding presence with its expansive portfolio in both the Innovative Medicine and MedTech segments. With..

BeOne Medicines Ltd. (ONC) Stock Analysis: Unveiling a 32% Potential Upside with Strong Buy Ratings

BeOne Medicines Ltd. (ONC), a prominent player in the biotechnology sector, is making waves with its remarkable potential upside of 32.22%, as highlighted by analyst ratings. Based in Basel, Switzerland,..

BioNTech SE (BNTX) Stock Analysis: Exploring a Potential 21% Upside with Strong Buy Ratings

BioNTech SE (NASDAQ: BNTX), a prominent player in the biotechnology industry, has carved a niche for itself in the global healthcare landscape with its innovative immunotherapies targeting cancer and infectious..

Incyte Corporation (INCY) Stock Analysis: Strong Revenue Growth and Strategic Pipeline Bolster Investor Confidence

In the dynamic world of biotechnology, Incyte Corporation (NASDAQ: INCY) stands out as a formidable player, combining a robust pipeline with impressive revenue growth. With a market capitalization of $13.28..

Natera, Inc. (NTRA): Investor Outlook Reveals 20% Upside Potential Amid Robust Revenue Growth

For investors focused on the healthcare sector, particularly in diagnostics and research, Natera, Inc. (NTRA) presents an intriguing opportunity. With a market capitalization of $21.91 billion, this Austin, Texas-based company..

Tenet Healthcare Corporation (THC) Stock Analysis: Navigating Opportunities with a 6.3% Upside Potential

Tenet Healthcare Corporation (NYSE: THC), a prominent player in the U.S. healthcare industry, offers a compelling investment opportunity as it navigates a complex landscape. With a market capitalization of $16.32..

Centene Corporation (CNC) Stock Analysis: Exploring the 143% Upside Potential

Centene Corporation (NYSE: CNC), a prominent player in the healthcare sector, has been capturing the attention of investors with its potential for significant upside. Currently priced at $31.44, Centene’s stock..

Amgen Inc. (AMGN) Stock Analysis: Healthcare Giant Offers 6.43% Potential Upside with Strong Dividend Yield

Amgen Inc. (NASDAQ: AMGN), a prominent player in the healthcare sector, continues to attract investor attention with its robust portfolio of biopharmaceutical products and a compelling combination of growth potential..

argenx SE (ARGX) Stock Analysis: A Biotech Powerhouse with 37% Upside Potential

argenx SE (ARGX), a prominent player in the biotechnology sector based in the Netherlands, has been capturing investor attention with its impressive growth trajectory and promising future potential. With a..

Mettler-Toledo International, Inc. (MTD) Stock Analysis: Navigating a 2.41% Potential Upside Amidst Market Challenges

Mettler-Toledo International, Inc. (NYSE: MTD), a formidable player in the healthcare sector’s diagnostics and research industry, stands as a key provider of precision instruments worldwide. Operating across the Americas, Europe,..

Haleon plc (HLN) Stock Analysis: Exploring a 16% Potential Upside in the Healthcare Sector

Haleon plc (HLN), a significant player in the healthcare sector, has been capturing investor attention with its robust portfolio of consumer healthcare products and a promising potential upside of 16.04%...

Waters Corporation (WAT) Stock Analysis: 10.17% Potential Upside Amid Strong Analyst Confidence

Waters Corporation (NYSE: WAT), a global leader in diagnostic and research solutions within the healthcare sector, presents a compelling opportunity for investors in search of steady growth and innovation in..

Danaher Corporation (DHR) Stock Analysis: What 20.85% Potential Upside Means for Investors

Danaher Corporation (NYSE: DHR), a major player in the healthcare sector, is drawing significant attention from investors, thanks to its robust market position and promising growth potential. With a market..

Edwards Lifesciences Corporation (EW) Stock Analysis: Navigating Growth in the Medical Device Sector

Edwards Lifesciences Corporation (NYSE: EW) stands as a cornerstone in the healthcare sector, specifically within the medical devices industry. Headquartered in Irvine, California, Edwards Lifesciences is renowned for its innovative..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds